Consun Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:1681 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
11 Apr 25	BuyHK$4,792,176	FMR LLC	Company	514,000	HK$9.32
05 Nov 24	BuyHK$4,039,603	Lion River I N.V.	Company	491,000	HK$8.23
17 Sep 24	BuyHK$546,480	Meng An	Individual	92,000	HK$5.94
16 Sep 24	BuyHK$2,022,999	Meng An	Individual	350,000	HK$5.78
13 Sep 24	BuyHK$1,710,999	Meng An	Individual	295,000	HK$5.80
12 Sep 24	BuyHK$4,853,518	Meng An	Individual	856,000	HK$5.67
11 Sep 24	BuyHK$5,758,438	Meng An	Individual	1,021,000	HK$5.64
10 Sep 24	BuyHK$2,885,262	Meng An	Individual	518,000	HK$5.57
05 Sep 24	BuyHK$1,531,200	Meng An	Individual	290,000	HK$5.28
04 Sep 24	BuyHK$4,639,702	Meng An	Individual	830,000	HK$5.59
03 Sep 24	BuyHK$5,650,397	Meng An	Individual	1,009,000	HK$5.60
02 Sep 24	BuyHK$5,357,997	Meng An	Individual	950,000	HK$5.64
29 Aug 24	BuyHK$505,800	Meng An	Individual	90,000	HK$5.62
28 Aug 24	BuyHK$1,903,999	Meng An	Individual	340,000	HK$5.60
05 Jul 24	BuyHK$7,669,997	Meng An	Individual	1,300,000	HK$5.90
04 Jul 24	BuyHK$286,500	Meng An	Individual	50,000	HK$5.73
03 Jul 24	BuyHK$690,030	Meng An	Individual	123,000	HK$5.61
06 Jun 24	SellHK$8,447,307	Quan Zhu	Individual	1,287,700	HK$6.56
06 Jun 24	BuyHK$5,163,673	Quan Zhu	Individual	1,287,700	HK$4.01
21 May 24	SellHK$61,767,294	Yubao An	Individual	9,219,000	HK$6.70

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1681?
Owner Type	Number of Shares	Ownership Percentage
VC/PE Firms	42,907,000	5.16%
Institutions	118,611,451	14.3%
General Public	291,225,228	35%
Individual Insiders	378,857,354	45.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 64.5% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
23.7%	Yubao An	197,324,000	HK$1.9b	-5.01%	no data
13.2%	Wai Po Young	110,050,000	HK$1.0b	0%	no data
5.16%	Lion River I N.V.	42,907,000	HK$405.0m	0%	40.45%
5.13%	FMR LLC	42,676,062	HK$402.9m	122%	no data
4.62%	Qian Li	38,424,899	HK$362.7m	0%	no data
3.98%	Meng An	33,058,455	HK$312.1m	46%	no data
2.16%	The Vanguard Group, Inc.	17,942,474	HK$169.4m	0%	no data
1.88%	UBS Asset Management AG	15,618,000	HK$147.4m	0%	no data
1.1%	Dimensional Fund Advisors LP	9,127,780	HK$86.2m	0.21%	no data
0.73%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	6,088,000	HK$57.5m	51%	no data
0.33%	Fullgoal Fund Management Co. Ltd.	2,771,000	HK$26.2m	0%	0.01%
0.33%	Goldman Sachs Asset Management, L.P.	2,750,000	HK$26.0m	0%	no data
0.31%	Norges Bank Investment Management	2,546,132	HK$24.0m	0%	no data
0.27%	AllianceBernstein L.P.	2,278,000	HK$21.5m	-8.2%	no data
0.25%	BlackRock, Inc.	2,119,000	HK$20.0m	3.57%	no data
0.24%	Bank of Singapore Limited, Asset Management Arm	1,989,310	HK$18.8m	0%	0.21%
0.18%	First Trust Advisors LP	1,521,188	HK$14.4m	-9.39%	no data
0.16%	Grantham Mayo Van Otterloo & Co. LLC	1,314,000	HK$12.4m	935%	no data
0.12%	China Southern Asset Management Co., Ltd.	1,000,000	HK$9.4m	0%	no data
0.12%	American Century Investment Management Inc	999,000	HK$9.4m	32.9%	no data
0.099%	State Street Global Advisors, Inc.	825,400	HK$7.8m	-1.43%	no data
0.099%	National Bank Trust Inc., Asset Management Arm	822,000	HK$7.8m	0%	0.02%
0.095%	Union Asset Management Holding AG	793,000	HK$7.5m	0%	no data
0.091%	Thrivent Investment Management Inc.	758,000	HK$7.2m	0%	no data
0.086%	AXA Investment Managers S.A.	714,000	HK$6.7m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/13 02:58
End of Day Share Price	2025/05/13 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Consun Pharmaceutical Group Limited is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Fangqi Dai	China Merchants Securities (HK) Co., Ltd
null null	CMB International Securities Limited
Trina Chen	Credit Suisse